EMEA Inspection Findings Portend Further Manufacturing Problems For Genzyme
This article was originally published in The Pink Sheet Daily
Executive Summary
Market analysts note growing concerns about biotech's ability to handle manufacturing difficulties at Allston Landing, Mass., plant.